Therapeutics News and Research

RSS

Mayo Clinic research advances treatment options for genitourinary cancers

Cancers of the reproductive and urinary organs, known as genitourinary cancers, affect millions of people worldwide each year. Yousef Zakharia, M.D., a Mayo Clinic medical oncologist, leads clinical research aimed at improving treatment results for patients with kidney, bladder and prostate cancers.

10 Nov 2026

Qureight’s fibrosis imaging biomarker selected by Contineum Therapeutics as a secondary endpoint in Phase 2 PROPEL-IPF clinical trial

Qureight, an end-to-end imaging company providing enterprise-grade imaging and precision endpoints for clinical trials for lung and heart disease, and Contineum Therapeutics, Inc. (Contineum), a clinical-stage biopharmaceutical company pioneering differentiated small molecule therapies for inflammatory and fibrotic diseases with significant unmet need, today announced that Qureight’s Fibr8™ quantitative imaging biomarker is being used as a secondary endpoint in Contineum’s PROPEL-IPF Phase 2 clinical trial examining the safety and efficacy of PIPE-791, Contineum’s lead drug candidate, in idiopathic pulmonary fibrosis (IPF) patients.

10 Nov 2026

Crystal Pharmatech completes ELDICO ED-1 installation; Dedicated MicroED now in routine service

Crystal Pharmatech, a science-driven CRO/CDMO specializing in solid-state research, preformulation studies, and formulation development and manufacturing for small-molecule drugs, today announced that installation of the ELDICO ED-1 electron diffractometer at its Suzhou, China R&D center is complete.

From ELDICO Scientific AG 10 Nov 2026

BioUK acquires certain key assets of SEHTA to strengthen support for life science SMEs across the UK

BioUK Ltd., the not-for-profit membership organization focused on catalyzing success in UK life sciences, today announced that it has acquired certain key assets of SEHTA (Science and Engineering Health Technologies Alliance) through an asset purchase agreement.

From BioUK 9 Nov 2026

Five AI models tackled 227 pharmacy exam questions. Here's where they struggled

Researchers evaluated five large language models using 227 infectious disease-related pharmacy examination questions and found that all achieved approximately 90% accuracy, with ChatGPT-4o-mini scoring highest at 91.2%. Accuracy was significantly lower for medicinal chemistry, clinical microbiology, higher-order cognitive questions, and image-containing questions, raising concerns about relying on AI-generated answers without independent verification.

9 Nov 2026

New monoclonal antibody therapy significantly lowers patient triglyceride levels

A phase 2b clinical trial led by Mass General Brigham Heart and Vascular Institute researchers shows that a monoclonal antibody therapy called MAR001 can significantly reduce triglyceride levels within 12 weeks for patients with high triglyceride levels.

9 Nov 2026

Qureight's fibrosis imaging biomarker selected by Contineum Therapeutics as a secondary endpoint in Phase 2 PROPEL-IPF clinical trial

Qureight, an end-to-end imaging company providing enterprise-grade imaging and precision endpoints for clinical trials for lung and heart disease, and Contineum Therapeutics, Inc. (Contineum), a clinical-stage biopharmaceutical company pioneering differentiated small molecule therapies for inflammatory and fibrotic diseases with significant unmet need, today announced that Qureight's Fibr8™ quantitative imaging biomarker is being used as a secondary endpoint in Contineum's PROPEL-IPF Phase 2 clinical trial examining the safety and efficacy of PIPE-791, Contineum's lead drug candidate, in idiopathic pulmonary fibrosis (IPF) patients.

From Qureight 9 Nov 2026

Modified zinc finger protein reduces brain plaques in Alzheimer's mice

A KAIST-led research team has found that a protein involved in gene regulation can suppress the harmful aggregation of amyloid-beta, a peptide associated with Alzheimer's disease.

9 Nov 2026

Combat Medical reports 68% high-grade recurrence-free survival at 12 months in BCG-unresponsive non-muscle invasive bladder cancer study

Combat Medical (Combat), a medical device company optimizing the delivery and efficacy of cancer therapeutics, today announced new real-world data showing 68% high-grade recurrence-free survival (HG-RFS) at 12 months in patients with Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC) after hyperthermic intravesical chemotherapy (HIVEC®) with mitomycin C.

9 Nov 2026

Biodegradable microneedle particles improve drug delivery through the skin

Your skin is remarkably good at keeping things out of your body. Typically, that's a positive. It becomes an issue when medicine needs to get in.

6 Nov 2026

MRM Health and Biocodex establish strategic partnership to strengthen future commercial supply capabilities for CORAL®-based medicines

MRM Health, a clinical-stage biotech developing microbiome-based therapies for immune-mediated diseases, and Biocodex, an independent French pharmaceutical company with more than 70 years of experience in the microbiome field, today announced the launch of a strategic partnership to establish specialized manufacturing capabilities for live biotherapeutic products.

6 Nov 2026

Temporary ultrasonic sensor provides continuous feedback during spinal cord healing

Following a $13.48 million dollar award from the defense department, a team of engineers and surgeons from Johns Hopkins Medicine have published their first proof-of-concept study that shows temporarily implanting a tiny ultrasonic device into the location of a spinal cord injury can be feasible, safe and potentially useful.

5 Nov 2026

Modified zinc finger scaffold suppresses microglial activation in mouse brain

A KAIST-led research team has found that a protein involved in gene regulation can suppress the harmful aggregation of amyloid-beta, a peptide associated with Alzheimer's disease. The approach also reduced the toxicity of protein aggregates that had already formed.

5 Nov 2026

Modern lifestyles may be changing our gut bacteria in unexpected ways

A global study of 1,015 adults across 12 countries found that industrialized lifestyles were associated with lower gut bacterial diversity, reduced microbial community stability, and increased markers of intestinal stress and immune activity. The researchers also found that a microbiome-based health index developed using industrialized populations performed poorly in less-industrialized communities, raising concerns about its applicability across diverse populations.

4 Nov 2026

Comprehensive genetic map offers new hope for tuberculosis treatments

Rockefeller scientists have created the most comprehensive map to date of how essential genes interact in Mycobacterium tuberculosis (Mtb), the bacterium responsible for tuberculosis (TB).

4 Nov 2026

Genetic family mapping uncovers hidden links across ALS and FTD

Researchers at the Macquarie University Brain Institute and Clinic have helped accelerate the search for disease-causing genes by building new genetic 'families'.

3 Nov 2026

Engineered beneficial bacteria reduce bloodstream infections after stem cell transplants

Researchers at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the country, and collaborators have pioneered a new approach to preventing dangerous bloodstream infections in patients receiving donor stem cell transplants for blood cancers.

3 Nov 2026

New study identifies biological mechanism driving therapy resistance in advanced prostate cancer

A multi-institutional collaborative study led by researchers at the University of Chicago and the Fred Hutchinson Cancer Center has identified a previously unknown biological mechanism that controls cell identity and treatment resistance in advanced prostate cancer.

3 Nov 2026

RNA-protein interactions reveal new coronavirus drug targets

A study led by researchers at the University of California San Diego School of Medicine and University of California, Riverside (UCR) School of Medicine has identified new targets for antiviral drugs against coronaviruses, including SARS-CoV-2, the virus that causes COVID-19.

3 Nov 2026

Mount Sinai receives NIH grant to study advanced MRI methods for locating seizures

Researchers at the Icahn School of Medicine at Mount Sinai have received more than $3 million from the National Institutes of Health (NIH) for a five-year study of advanced magnetic resonance imaging (MRI) methods that may help locate seizure-causing brain regions in people with drug-resistant epilepsy.

2 Nov 2026

Therapeutics News and Research

Mayo Clinic research advances treatment options for genitourinary cancers

Qureight’s fibrosis imaging biomarker selected by Contineum Therapeutics as a secondary endpoint in Phase 2 PROPEL-IPF clinical trial

Crystal Pharmatech completes ELDICO ED-1 installation; Dedicated MicroED now in routine service

BioUK acquires certain key assets of SEHTA to strengthen support for life science SMEs across the UK

Five AI models tackled 227 pharmacy exam questions. Here's where they struggled

New monoclonal antibody therapy significantly lowers patient triglyceride levels

Qureight's fibrosis imaging biomarker selected by Contineum Therapeutics as a secondary endpoint in Phase 2 PROPEL-IPF clinical trial

Modified zinc finger protein reduces brain plaques in Alzheimer's mice

Combat Medical reports 68% high-grade recurrence-free survival at 12 months in BCG-unresponsive non-muscle invasive bladder cancer study

Biodegradable microneedle particles improve drug delivery through the skin

MRM Health and Biocodex establish strategic partnership to strengthen future commercial supply capabilities for CORAL®-based medicines

Temporary ultrasonic sensor provides continuous feedback during spinal cord healing

Modified zinc finger scaffold suppresses microglial activation in mouse brain

Modern lifestyles may be changing our gut bacteria in unexpected ways

Comprehensive genetic map offers new hope for tuberculosis treatments

Genetic family mapping uncovers hidden links across ALS and FTD

Engineered beneficial bacteria reduce bloodstream infections after stem cell transplants

New study identifies biological mechanism driving therapy resistance in advanced prostate cancer

RNA-protein interactions reveal new coronavirus drug targets

Mount Sinai receives NIH grant to study advanced MRI methods for locating seizures

Understanding the DNA Damage Response in Innate Immunity eBook

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News